Problems associated with "generic" topical medications.
Fisher
A A
AA
New York University Medical School.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D003879:Dermatologic Agents / Q000009:adverse effects*; D005029:Ethylenediamines / Q000009:adverse effects; D006801:Humans; D006854:Hydrocortisone; D009761:Nystatin / Q000009:adverse effects; D009824:Ointments; D010592:Pharmaceutic Aids / Q000009:adverse effects*; D013810:Therapeutic Equivalency
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005029:Ethylenediamines; D009824:Ointments; D010592:Pharmaceutic Aids; D009761:Nystatin; D006854:Hydrocortisone